In new research published today, UW–Madison researchers reported a new nanoparticle-based treatment for sepsis that delivers anti-inflammatory molecules and antibiotics.
Karo Barsamian
Treating Antimicrobial Resistant Infections: A Nano-scale Approach with Big Impacts
Antimicrobial-resistant (AMR) infections are predicted to kill 10 million people each year by 2050—up from 700,000 in 2019—and force 24 million people into extreme poverty as early as 2030. Yet, the pharmaceutical industry has divested from the antibiotic resistance crisis, investing instead in more lucrative types of drugs.